We are live on
!
Find out more
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
CTIC
Delisted
CTIC was delisted on the 23rd of June, 2023.
75 hedge funds and large institutions have $25.6M invested in CTI BioPharma Corp. (DE) Common Stock in 2018 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 16 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
38% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 16
5% less funds holding
Funds holding: 79 → 75 (-4)
27% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 15
67% less capital invested
Capital invested by funds: $76.7M → $25.6M (-$51M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
75
Holders Change
-4
Holders Change %
-5.06%
% of All Funds
1.67%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
11
Increased
22
Reduced
16
Closed
15
Calls
$34K
Puts
–
Net Calls
+$34K
Net Calls Change
-$64K
Top Buyers
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.05M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.45M |
| 3 |
AG
Algert Global
San Francisco,
California
|
-$733K |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$246K |
| 5 |
JP Morgan Chase
New York
|
-$242K |
